- Dr Wilkins to take on new role effective immediately (12th June)
- Joins pharmaceutical company after serving as CMO at Lycera
Zyla Life Sciences (OTCQX:ZCOR) has named Dr. H. Jeffrey Wilkins as chief medical officer (CMO) as the company looks to strengthen its portfolio of approved medications with new developments and products.
Dr Wilkins joins Zyla after previously serving in the same position at Lycera, where he was at the forefront of oncology development. He will also become a senior vice president.
“With extensive clinical development, medical affairs and product evaluation experience, Dr. Wilkins brings invaluable capabilities as we continue to grow Zyla Life Sciences,” CEO Bob Radie said in a statement on Wednesday.